Insulin Syringe Scales: U-100, Capacity, and Safety

An insulin syringe is a medical device labeled for a particular insulin concentration and route. It is not a generic peptide-measuring device. Units are not a universal volume unit: the meaning of a marked value depends on the syringe scale, the drug concentration, and the product-specific instructions.

This guide explains labels and arithmetic so readers can recognize medication-error risks. It does not recommend an insulin syringe for an unapproved research product, choose a device, establish a dose, or teach injection technique. A clinician or pharmacist should resolve any mismatch among the prescription, product label, dispensed concentration, and supplied device before use.

The three labels people often confuse

Current FDA device summaries describe U-100 insulin syringes as single-use devices for subcutaneous administration of insulin at 100 units/mL. Models can have 0.3 mL, 0.5 mL, or 1 mL capacity. Those capacities do not create new insulin concentrations.

Naming check: A 0.5 mL U-100 syringe is not a “U-50” syringe. A 0.3 mL U-100 syringe is not a “U-30” syringe. They remain U-100-scale devices whose maximum marked capacities may be 50 or 30 U-100 scale marks.

U-100 volume arithmetic

For a syringe actually labeled for U-100 insulin, the scale corresponds to 100 insulin units per milliliter. The volume relationship is:

volume in mL = U-100 scale value / 100
U-100 scale value = volume in mL × 100

This table is a scale conversion, not a dose recommendation. It does not determine how much of a non-insulin drug to administer. It also does not apply to a U-40 syringe, a U-500 syringe, a pen, or another device.

Why U-40, U-100, and U-500 are not interchangeable

• U-40 means 40 insulin units/mL and requires a matching labeled device and instructions.
• U-100 means 100 insulin units/mL and requires a U-100-compatible device and instructions.
• U-500 means 500 insulin units/mL. The current HUMULIN R U-500 label says its vial presentation must be used only with a dedicated U-500 insulin syringe and without dose conversion.
• Pens are separate delivery systems. The HUMULIN R U-500 label warns not to transfer insulin from its pen into a syringe because overdose and severe hypoglycemia can occur.

The ratio between two concentration labels is not permission to improvise a conversion. Product-specific labeling may require a dedicated device and expressly prohibit substitution.

“Units” can conceal a medication error

FDA reported adverse events involving compounded injectable semaglutide in multiple-dose vials. Contributing factors included varying concentrations, unfamiliarity with self-injection, and confusion among milligrams, milliliters, and “units.” In several reports, people instructed to measure 5 marks (0.05 mL) on a 1 mL U-100 syringe instead drew to 50 marks. Reported overdoses were five to 20 times the intended dose, and some people required hospitalization.

The lesson is broader than one drug: a bare instruction such as “take 5 units” is incomplete when the unit system, concentration, device, and corresponding volume are not unambiguous. Do not infer these details from an online calculator, another product, or a previous prescription.

Before measuring a prescribed product, the following should agree exactly:

1. Product and formulation
2. Labeled concentration, including its units
3. Prescribed amount and frequency
4. Corresponding volume, when applicable
5. Device type and scale
6. Product- and device-specific instructions

If any item is missing or conflicts, stop and ask the prescriber or dispensing pharmacist to reconcile it.

Capacity is not graduation or accuracy

A barrel's maximum capacity does not tell you its smallest marked increment. Graduation patterns vary by manufacturer and model, even among devices with the same capacity. Read the exact packaging and instructions rather than assuming every small barrel has the same marks.

Also distinguish:

• Graduation: the printed increment between scale marks
• Capacity: the maximum marked volume
• Accuracy claim: performance established for the specific device and conditions
• Dead space: residual volume affected by the barrel, hub, needle, and connection design

A calculated result smaller than a device's marked graduation is not made measurable by displaying more decimal places. Device selection, deliverable volume, and acceptable precision belong to the prescription, product labeling, and professional instructions.

Device details are product-specific

Needle gauge, length, attachment design, safety mechanism, route, site, and technique vary across devices and products. FDA device summaries show that cleared insulin-syringe models can differ on each of these characteristics. A generic chart cannot choose them for an individual or repurpose a device beyond its labeling.

Check the unopened package and instructions for:

• Manufacturer, model, and unique device identifier when present
• Intended drug concentration and route
• Barrel capacity and graduation pattern
• Needle gauge, length, and fixed or detachable design
• Sterile, single-use status and intact packaging
• Expiration date, storage conditions, and visible damage
• Current recalls or safety notices when there is a concern

For contamination controls, disposal, and the boundary between general safety and product-specific technique, use the peptide injection safety guide. CDC's injection-safety principle is one needle, one syringe, only one time. FDA recommends immediate disposal of used sharps in an FDA-cleared sharps container when available and following community-specific disposal rules.

Using the PepGuide calculator safely

The peptide calculator models user-entered mass, diluent volume, concentration, draw volume, and U-100 scale arithmetic. Its 1 mL, 0.5 mL, and 0.3 mL options all describe U-100 scale devices with different capacities.

The output is not a prescribed dose and does not verify:

• Product identity, purity, sterility, or regulatory status
• Whether a diluent, concentration, or route is appropriate
• Whether a device is compatible or precise enough
• Preparation, storage, stability, or in-use period
• Patient-specific safety or clinical instructions

Use the calculator to audit arithmetic already established from authoritative instructions—not to create those instructions.

How PepGuide evaluated this topic

This page prioritizes current FDA device summaries, FDA medication-error communications, current prescribing information in DailyMed, and CDC injection-safety guidance. Device examples show why concentration, capacity, and design must be kept separate; they are not endorsements of a manufacturer or model.

For the wider evidence process, see our research methodology, sourcing and commercial policy, and question-led use-case map. Commercial records, where available, appear separately in the source directory and do not determine this guide's conclusions.

References

1. U.S. Food and Drug Administration. FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products. July 26, 2024.
2. U.S. Food and Drug Administration. 510(k) Summary K260208: Ultra-Fine SAFETY Insulin Syringe. July 10, 2026.
3. U.S. Food and Drug Administration. 510(k) Summary K223453: U-40 and U-100 Insulin Syringe. March 6, 2023.
4. DailyMed. HUMULIN R U-500 prescribing information. U.S. National Library of Medicine.
5. Centers for Disease Control and Prevention. Preventing Unsafe Injection Practices. March 26, 2024.
6. U.S. Food and Drug Administration. Sharps Disposal Containers.
7. U.S. Food and Drug Administration. Medication Errors Related to CDER-Regulated Drug Products.